Compass Therapeutics, Inc. (CMPX) Tops Q4 EPS by 1c

Compass Therapeutics, Inc. (NASDAQ: CMPX) reported Q4 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Compass Therapeutics, Inc. (CMPX) click here.

You May Also Be Interested In

• Microsoft plans data center push to triple its computing power - Bloomberg
• Copart (CPRT) Misses Q4 EPS by 4c
• Champions Oncology (CSBR) Tops Q1 EPS by 6c